Trial intelligence / Profile preview

Preoperative Acetaminophen-Codeine-Caffeine for IANB Success in Pulpitis

NCT04202406Completed

Sponsor
Cairo University
Start
Jan 2021
Primary completion
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in irreversible pulpitis comparing Acetaminophen + Codeine + Caffeine, Acetaminophen and Placebo (3 arms). Primary endpoint: Success of mandibular inferior alveolar nerve block anesthesia. Started Jan 2021; status: completed.

02

Drugs

acetaminophencodeinecaffeine
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on NCT04202406.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04202406.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call